Protalix BioTherapeutics, Inc. (PLX)

USD 1.71

(-1.72%)

Gross Profit Summary of Protalix BioTherapeutics, Inc.

  • Protalix BioTherapeutics, Inc.'s latest annual gross profit in 2023 was 42.51 Million USD , up 51.58% from previous year.
  • Protalix BioTherapeutics, Inc.'s latest quarterly gross profit in 2024 Q2 was 4.01 Million USD , up 250.61% from previous quarter.
  • Protalix BioTherapeutics, Inc. reported a annual gross profit of 28.04 Million USD in annual gross profit 2022, up 27.48% from previous year.
  • Protalix BioTherapeutics, Inc. reported a annual gross profit of 22 Million USD in annual gross profit 2021, down -57.71% from previous year.
  • Protalix BioTherapeutics, Inc. reported a quarterly gross profit of 4.01 Million USD for 2024 Q2, up 250.61% from previous quarter.
  • Protalix BioTherapeutics, Inc. reported a quarterly gross profit of 6.5 Million USD for 2023 Q1, up 4.55% from previous quarter.

Annual Gross Profit Chart of Protalix BioTherapeutics, Inc. (2023 - 1996)

Historical Annual Gross Profit of Protalix BioTherapeutics, Inc. (2023 - 1996)

Year Gross Profit Gross Profit Growth
2023 42.51 Million USD 51.58%
2022 28.04 Million USD 27.48%
2021 22 Million USD -57.71%
2020 52.02 Million USD 18.78%
2019 43.79 Million USD 75.63%
2018 24.93 Million USD 521.74%
2017 4.01 Million USD 400.75%
2016 801 Thousand USD -77.96%
2015 3.63 Million USD -40.49%
2014 6.1 Million USD 0.36%
2013 6.08 Million USD -76.85%
2012 26.28 Million USD 1721.21%
2011 1.44 Million USD 161.59%
2010 -2.34 Million USD 26.48%
2009 -3.18 Million USD 0.0%
2008 - USD 0.0%
2007 - USD -100.0%
2006 115 Thousand USD 0.0%
2005 - USD 0.0%
2004 - USD 0.0%
2003 - USD 0.0%
2002 - USD 0.0%
2001 - USD -100.0%
2000 1.00 USD -100.0%
1999 871.15 Thousand USD -49.65%
1998 1.73 Million USD 0.0%
1997 - USD 0.0%
1996 - USD 0.0%

Peer Gross Profit Comparison of Protalix BioTherapeutics, Inc.

Name Gross Profit Gross Profit Difference
AIM ImmunoTech Inc. 160 Thousand USD -26470.0%
Ampio Pharmaceuticals, Inc. -250 Thousand USD 17104.8%
Armata Pharmaceuticals, Inc. -29.24 Million USD 245.385%
Actinium Pharmaceuticals, Inc. -709 Thousand USD 6096.051%
Azitra, Inc. 260.45 Thousand USD -16222.456%
Can-Fite BioPharma Ltd. 743 Thousand USD -5621.669%
Chromocell Therapeutics Corporation -2.57 Million USD 1748.124%
Calidi Biotherapeutics, Inc. -1.25 Million USD 3484.713%
CEL-SCI Corporation -3.95 Million USD 1173.987%
iBio, Inc. -1.02 Million USD 4247.512%
Lineage Cell Therapeutics, Inc. 8.27 Million USD -413.802%
MAIA Biotechnology, Inc. - USD -Infinity%
Matinas BioPharma Holdings, Inc. -13.39 Million USD 417.42%
Navidea Biopharmaceuticals, Inc. -119.29 Thousand USD 35736.028%
NovaBay Pharmaceuticals, Inc. 7.89 Million USD -438.467%
NanoViricides, Inc. -759.01 Thousand USD 5700.951%
Oragenics, Inc. -15.45 Million USD 375.106%
BiomX Inc. -1.22 Million USD 3561.889%
BiomX Inc. -1.22 Million USD 3561.889%
Palatin Technologies, Inc. 4.39 Million USD -867.842%
Scorpius Holdings, Inc. -2.21 Million USD 2018.051%